Literature DB >> 1462762

Allocortical neurofibrillary changes in progressive supranuclear palsy.

H Braak1, K Jellinger, E Braak, J Bohl.   

Abstract

Silver techniques for intraneuronal cytoskeleton abnormalities (neurofibrillary tangles and neuropil threads) and extracellular A4-amyloid deposits were used to examine lesions of the cerebral cortex in six cases of progressive supranuclear palsy (three were mentally unimpaired and three showed moderate degrees of dementia). Deposits of A4-amyloid protein occurred in small numbers or were absent. Neurofibrillary tangles and neuropil threads were present in all cases and were largely confined to the allocortex. A characteristic pattern of changes was found in the entorhinal cortex. The three mentally unimpaired individuals had mild cortical changes virtually confined to the transentorhinal region while all of the demented patients showed severe destruction of the superficial cellular layer in both the transentorhinal and entorhinal region. This pattern of allocortical destruction closely resembles that seen in clinically incipient Alzheimer's disease or in mentally impaired cases of Parkinson's disease. The entorhinal region receives dense input from isocortical association areas and projects via the perforant path to the hippocampal formation. The cells of origin of major portions of the perforant path are located within the superficial entorhinal cellular layer. Destruction of this layer partially or totally disconnects the hippocampus from the isocortex. The specific pattern of entorhinal destruction is considered to contribute to cognitive impairment and personality changes, frequently seen in patients with progressive supranuclear palsy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1462762     DOI: 10.1007/bf00304466

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  46 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

Review 2.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

3.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

4.  Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases.

Authors:  K Jellinger; H Braak; E Braak; P Fischer
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 5.  Parkinson's disease and dementia.

Authors:  Y Agid; M Ruberg; B Dubois; B Pillon; G Cusimano; R Raisman; R Cash; F Lhermitte; F Javoy-Agid
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

6.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

7.  [Frontal syndrome of progressive supranuclear palsy].

Authors:  J Cambier; M Masson; F Viader; J Limodin; A Strube
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

8.  Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.

Authors:  A Probst; D Langui; C Lautenschlager; J Ulrich; J P Brion; B H Anderton
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.

Authors:  P R Hof; A Delacourte; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Progressive supranuclear palsy: clinico-pathological and biochemical studies.

Authors:  K Jellinger; P Riederer; M Tomonaga
Journal:  J Neural Transm Suppl       Date:  1980
View more
  8 in total

1.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

2.  Distribution of amyloid plaques in the cerebellum in Alzheimer's disease.

Authors:  K A Jellinger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 3.  Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.

Authors:  D W Dickson
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

4.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.

Authors:  P Vermersch; Y Robitaille; L Bernier; A Wattez; D Gauvreau; A Delacourte
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy.

Authors:  T Uchihara; K Mitani; H Mori; H Kondo; M Yamada; K Ikeda
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Achromatic neurons in the cortex of progressive supranuclear palsy.

Authors:  I R Mackenzie; L P Hudson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Subtle Alterations in Spatial Memory Induced by Amyloid Peptides Infusion in Rats.

Authors:  Priscila Tavares Macêdo; Antônio C Q Aquino; Ywlliane S R Meurer; Luiz E M Brandão; Clarissa L C Campêlo; Ramon H Lima; Marcos R Costa; Alessandra M Ribeiro; Regina H Silva
Journal:  Front Aging Neurosci       Date:  2018-01-30       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.